Profile · Medical Technology
Ehud Bendory
The engineer-turned-CEO building sterile, single-use endoscopes that help surgeons see places older tools never could - from a small Israeli town, with a global footprint.
The engineer-turned-CEO building sterile, single-use endoscopes that help surgeons see places older tools never could - from a small Israeli town, with a global footprint.
Ehud Bendory runs a company most people will never notice - and that is roughly the point. The devices his team at 3NT Medical builds are meant to be picked up, used once, and thrown away, leaving nothing behind but a clearer view inside the human ear and sinus.
Bendory is the chief executive and co-founder of 3NT Medical, an Israeli company headquartered in Rosh Ha'ayin, a small city near Tel Aviv. The company designs single-use endoscopes for ear, nose, and throat specialists - the kind of narrow, maneuverable scopes that let a surgeon navigate anatomy that standard instruments struggle to reach.
The idea sounds simple once you hear it. Traditional endoscopes are reusable, expensive, and require careful cleaning and sterilization between procedures. Bendory's bet was that a well-designed disposable scope could sidestep much of that friction while giving surgeons a fresh, sterile tool every time. It is the sort of unglamorous, practical rethink that takes years to earn the trust of the people who actually use it.
Today the company's product line centers on two scopes with bird names: the Colibri Micro ENT Scope and the Peregrine Drivable ENT Scope. Both have earned FDA 510(k) clearance and CE marking, the regulatory milestones that separate a promising prototype from a device a hospital can order.
Before he was a CEO, Bendory was trained to think in systems. He holds a B.Sc. in electrical engineering and an MBA, a pairing that shows up in how 3NT talks about its products - part precision instrument, part commercial argument. He also served as an officer in the IDF's Unit 8200, the signals intelligence unit that has become an unlikely finishing school for a generation of Israeli technology founders.
His industry apprenticeship came at Medi-Tate, an Israeli medical device company focused on non-surgical treatment approaches, where he served as vice president of business development. That role - sitting between the engineering bench and the customer - is a recurring theme in his career. He is the kind of founder who has spent as much time explaining a device to the people who buy it as designing the thing itself.
In 2013 he co-founded 3NT Medical with his brother, Eran Bendory, who served as the company's chief technologist. It made the venture as much a family project as a business one: one brother shaping the technology, the other shaping the company around it.
"Their investment is a strong validation of the team's efforts to establish single-use endoscopy platforms as the next standard of care in ENT."
3NT's scopes are built around a single guiding question: how do you reach narrow anatomy without asking the surgeon to fight the tool? The Colibri is a micro scope, prized for getting close-up views in tight spaces. The Peregrine is drivable - steerable through the winding geometry of the nasal and sinus passages - and is designed for single-hand use with integrated features that keep the surgeon's workflow simple.
A compact, single-use scope built for close-up visualization in narrow ear anatomy. FDA 510(k) cleared.
A steerable, single-use scope designed to navigate the sinus passages with single-hand control and integrated irrigation.
In 2018, 3NT announced the initial closing of a $15 million financing round led by HOYA Corporation, the Japanese optics and medtech company. For HOYA it was a notable move: its first venture investment in an Israeli company. For Bendory, it was validation from a strategic partner that understood the optics and imaging side of the business better than most.
The company later raised a Series C round in 2021 to keep developing and commercializing its platform. Along the way it also drew support from the European Union's Horizon 2020 research and innovation program - a mix of strategic, venture, and public funding that reflects how small medtech companies stitch together the capital to cross the long road to market.
None of it happened fast. That is the honest texture of medical device work: clearances take years, adoption takes longer, and the reward for getting it right is a surgeon who reaches for your tool without thinking twice. Bendory has spent the better part of a decade chasing exactly that kind of quiet trust.
Ask what Bendory is really trying to build and the answer is less about any single scope than about a shift in habit. He has said plainly that the goal is to establish single-use endoscopy platforms as the next standard of care in ENT. That is an ambitious sentence dressed in modest language - it means convincing an entire specialty to change how it works, one procedure at a time.
He fits a familiar Israeli archetype - the 8200 alum with an engineering degree and a company of his own - but the work itself resists hype. There is no viral consumer app here, no overnight scale. There is a small team in Rosh Ha'ayin, a pair of cleared devices, a patient investor base, and a founder who seems content to let the tools do the talking.